Park Medi World Limited Announces Investor Presentation for Audited Q4 & FY26 Results
Park Medi World Limited reported record FY'26 results with revenue at ₹16,794 million (up 21% YoY) and net profit at ₹2,736 million (up 27% YoY). The company added 610 beds in FY'26 through acquisitions and greenfield projects, including a 360-bed facility in Agra and a 350-bed project in Panchkula.
The announcement includes audited financial results for the full year and quarter, showcasing strong growth metrics and strategic expansion, which are material information for investors.
The company reported record financial and operational performance, significant revenue and profit growth, and strategic capacity expansion through acquisitions and greenfield projects, indicating a positive outlook.
Park Medi World Limited has announced the release of its Investor Presentation covering the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. The presentation details the company's financial performance and operational highlights.
The company has achieved record financial and operating performance in FY'26, with revenue reaching ₹16,794 million, a 21% year-over-year increase. EBITDA grew by 20% YoY to ₹4,443 million, and Net Profit saw a significant rise of 27% YoY to ₹2,736 million. The company also reported an increase in bed capacity to 3,610 beds and improved occupancy rates to 64.1% in Q4 FY'26.
Key strategic initiatives included the integration of acquired assets and expansion of facilities. The company acquired KP Institute of Medical Sciences in Agra with 360 beds and Krishna Super Speciality Hospital in Bhatinda with 250 beds. Additionally, construction was completed for the largest greenfield project, Park Hospital in Panchkula, with 350 beds, slated for commissioning in April 2026. The company also announced a 150-bed expansion for Grecian Super Specialty Hospital in Mohali.
Park Medi World highlighted its proven integration and value creation from acquisitions, with acquired hospitals contributing significantly across financial metrics. The company emphasized its commitment to disciplined capital allocation, balance sheet strength, and measured expansion, aiming to fund future growth entirely through internal accruals.
What to do with a filing like this
Park Medi World Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Park Medi World Limited. Read the original for the full detail.